GILA THERAPEUTICS, INC.

Profile

Company Names

GILA THERAPEUTICS, INC.

Addresses

5420 HIGHWOOD DRIVE WEST, EDINA, MN 55436

5420 HIGHWOOD DRIVE WEST, MINNEAPOLIS, MN 55436

198TREMONT STREET, BOSTON, MA 02216

5420 HIGHWOOD DR W, MINNEAPOLIS, MN 55436

1712 HUMBOLT AVENUE SOUTH, MINNEAPOLIS, MN 55403

Phone Numbers

(612) 805-9054
612-805-9054

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2014

State Incorporated:

DELAWARE

Total Amount Raised:

$5,664,413.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2023-11-22 
$399,572.00 
$10,000,000.00 
$9,600,428.00 
Debt 
4
2022-11-15 
$355,522.00 
$5,000,000.00 
$4,644,478.00 
Equity 
3
2021-01-29 
$1,250,000.00 
$1,250,000.00 
$0.00 
Debt 
2
2019-03-04 
$314,434.00 
$2,000,000.00 
$1,685,566.00 
Equity 
1
2016-04-15 
$3,344,885.00 
$4,000,000.00 
$655,115.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ANDRES 
 
ACOSTA 
PROMOTER
GILA THERAPEUTICS, INC.   |  PHENOMIX SCIENCES LLC   |  PHENOMIX SCIENCES, INC.
TIMOTHY 
 
BARBERICH 
DIRECTOR
HEARTWARE INTERNATIONAL, INC.   |  TOKAI PHARMACEUTICALS INC   |  EUTHYMICS BIOSCIENCE, INC.   |  FREQUENCY THERAPEUTICS, INC.   |  GI DYNAMICS, INC.   |  TSCAN THERAPEUTICS, INC.   |  VERASTEM, INC.   |  GILA THERAPEUTICS, INC.
MICHAEL 
R. 
CARDENAS 
PROMOTER
GILA THERAPEUTICS, INC.
CHRISTOPHER 
 
DE SOUZA 
DIRECTOR
MELLITUS, LLC   |  GILA THERAPEUTICS, INC.   |  MOSYLE CORP   |  SECURENDS, INC.   |  FIFTH ASSET, INC.   |  RARESTEP, INC.
CHRISTOPHER 
 
DESOUZA 
DIRECTOR
GILA THERAPEUTICS, INC.
JON 
 
FREEMAN 
EXECUTIVE OFFICER
SECURED INCOME FUND-II, LLC   |  MEDAFOR INC   |  PRIVATE CAPITAL FUND, LLC   |  EMBOMEDICS, INC.   |  VIDERI INC.   |  GILA THERAPEUTICS, INC.   |  REAL ESTATE GROWTH FUND, LLC   |  HISTOSONICS, INC.   |  ONEMEDNET CORP   |  TAS MEDICAL, INC.   |  SECURED INCOME FUND-II, LLC.
RICHARD 
 
HORAN 
DIRECTOR
MNEMOSYNE PHARMACEUTICALS INC   |  GILA THERAPEUTICS, INC.
SANGEETA 
 
KASHYAP 
EXECUTIVE OFFICER
GILA THERAPEUTICS, INC.
SCOTT 
 
SCHORER 
EXECUTIVE OFFICER, DIRECTOR
GI DYNAMICS, INC.   |  GILA THERAPEUTICS, INC.   |  ELLESS, LLC
PRAVEEN 
 
TYLE 
DIRECTOR
EYEGATE PHARMACEUTICALS INC   |  LEXICON PHARMACEUTICALS, INC.   |  MAXWELL BIOSCIENCES, INC.   |  KIORA PHARMACEUTICALS INC   |  SKYE BIOSCIENCE, INC.   |  GILA THERAPEUTICS, INC.   |  ORION BIOTECHNOLOGY CANADA LTD.
THOMAS 
 
VASICEK 
EXECUTIVE OFFICER
GILA THERAPEUTICS, INC.
THOMAS 
J. 
VASICEK 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
GILA THERAPEUTICS, INC.
TOM 
 
VASICEK 
EXECUTIVE OFFICER
GILA THERAPEUTICS, INC.
SERGEI 
 
ZOLUTUKHIN 
PROMOTER
GILA THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-12-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2023-11-22 
2022-11-29
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-11-15 
2021-11-12
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-01-29 
2021-02-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2021-01-29 
2019-03-13
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-04 
2017-04-18
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-15 
2016-05-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-04-15 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#